logo
Select company
Select metric
$ 0.42EBITDA per Share
VS
Market
41
Sector
78
Industry
92
History
94
$ 3.2Close
$ 0.43 - $ 3.45 52-Week Range
Ticker Information

Ticker

CTMX

Company Name

CYTOMX THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CYTOMX THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CTMX - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ 54.08M$ 0.421129.08M
3/31/2025$ 47.7M$ 0.55187.12M
12/31/2024$ 37.95M$ 0.45184.44M
9/30/2024$ 20.89M$ 0.25185.09M
6/30/2024$ 20.88M$ 0.25184.88M
3/31/2024$ 26.34M$ 0.32182.03M
12/31/2023$ 9.23M$ 0.13173.81M
9/30/2023$ -20.59M$ -0.26180.73M
6/30/2023$ -49.64M$ -0.75166.54M
3/31/2023$ -72.82M$ -1.1166.25M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CYTOMX THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -1.42.
  • Over the past 5 years, CYTOMX THERAPEUTICS INC's average EBITDAPS has been $ -0.58.
  • The median EBITDAPS for CYTOMX THERAPEUTICS INC during this period was $ -0.89
  • CYTOMX THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ 0.55.
  • The lowest EBITDAPS recorded by CYTOMX THERAPEUTICS INC in the same timeframe $ -1.42

CYTOMX THERAPEUTICS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ -2.66RGNX : REGENXBIO INC $ -2.52HRTX : HERON THERAPEUTICS INC $ 0.03ADCT : ADC THERAPEUTICS SA $ -1.01GLUE : MONTE ROSA THERAPEUTICS INC $ 0.45YMAB : Y-MABS THERAPEUTICS INC $ -0.58XNCR : XENCOR INC $ -1.66NRC : NATIONAL RESEARCH CORP $ 1.51SPOK : SPOK HOLDINGS INC $ 1.28VNDA : VANDA PHARMACEUTICALS INC $ -1.31

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for CYTOMX THERAPEUTICS INC is calculated as follows: EBITDA [ $ -65.45M ] / (Shares WA [ 46.2M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -1.42 ]

CTMX - EBITDA per Share, Last 5 years

$ -1.42

Minimum

Dec 31, 2022

$ 0.55

Maximum

Mar 31, 2025

$ -0.58

Average

$ -0.89

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26